6-1BS Kuwait Society of Allergy and Clinical Immunology Sister Society Session: Omalizumab (Anti-IgE) for Asthma

Monday, 5 December 2011
Coral Kingdom 1 (Fiesta Americana)

Mona Al-Ahmad, FRCPC , Allergy, AL-Rashed allergy Centre, Kuwait, Kuwait, Kuwait

Learning Objectives:
(1) To discuss the use of Omalizumab in severe persistent allergic asthma, Kuwait experience

(2) To discuss the long term use of omalizumab in severe persistent allergic asthma (two years experience in Kuwait).